Manufacturer record
Vee Excel Drugs & Pharmaceuticals (P) Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Vee Excel Drugs & Pharmaceuticals (P) Ltd (Uttar Pradesh) were declared Not of Standard Quality between September 2022 and July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: G240147/2, Trypsin & let Chymotryp (exp Aug 2026). DCA Vijayawada, Andhara Pradesh (state lab) found it not of standard quality: The sample failed in Assay (Label claim 13.6%) for Trypsin-Chymotrypsin. Listed in the July 2025 alert.
Records by type
2 records linked to Vee Excel Drugs & Pharmaceuticals (P) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Trypsin & let Chymotryp | Batch G240147/2Mfg Sep 2024 · Exp Aug 2026 | The sample failed in Assay (Label claim 13.6%) for Trypsin-Chymotrypsin.Assay | DCA Vijayawada, Andhara PradeshState lab | Jul 2025 |
| PROLONGED- RELEASE SODIUM VALPROATE TABLET BP 500 mg | Batch G210163Mfg Sep 2021 · Exp Aug 2023 | DescriptionDescription | CDTL HyderabadCDSCO lab | Sep 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.